SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001819790-23-000041
Filing Date
2023-06-21
Accepted
2023-06-21 18:08:51
Documents
3
Period of Report
2023-06-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1687385320.html 4  
1 FORM 4 wk-form4_1687385320.xml 4 5794
2 EX-24 a2023-05x26secpoabilllin.htm EX-24 642
3 a2023-05x26secpoabilllin001.jpg GRAPHIC 201928
  Complete submission text file 0001819790-23-000041.txt   286033
Mailing Address ONE SANSOME STREET SUITE 1650 SAN FRANCISCO CA 94104
Business Address
LINK WILLIAM J PHD (Reporting) CIK: 0001228684 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39614 | Film No.: 231031055

Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Issuer) CIK: 0001819790 (see all company filings)

IRS No.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)